Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
66
CALM Quote, Financials, Valuation and Earnings
Last price:
$106.77
Seasonality move
:
0.46%
Day range:
$103.82 - $106.94
52-week range:
$63.37 - $116.41
Dividend yield:
6.34%
P/E ratio:
5.28x
P/S ratio:
1.38x
P/B ratio:
2.20x
Volume:
1.1M
Avg. volume:
753.2K
1-year change:
62.8%
Market cap:
$5.2B
Revenue:
$2.3B
EPS (TTM):
$20.23
Analysts' Opinion
-
Consensus RatingCal-Maine Foods has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $105.33, Cal-Maine Foods has an estimated downside of -1.38% from its current price of $106.81.
-
Price Target UpsideAccording to analysts, the highest upside price target is $108.00 representing 1.11% upside increase from its current price of $106.81.
Fair Value
-
According to the consensus of 3 analysts, Cal-Maine Foods has -1.38% downside to fair value with a price target of $105.33 per share.
CALM vs. S&P 500
-
Over the past 5 trading days, Cal-Maine Foods has overperformed the S&P 500 by 5.39% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cal-Maine Foods does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cal-Maine Foods has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Cal-Maine Foods reported revenues of $1.4B.
Earnings Growth
-
Cal-Maine Foods has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Cal-Maine Foods reported earnings per share of $10.38.
Enterprise value:
4B
EV / Invested capital:
--
Price / LTM sales:
1.38x
EV / EBIT:
3.13x
EV / Revenue:
1.05x
PEG ratio (5yr expected):
0.02x
EV / Free cash flow:
4.66x
Price / Operating cash flow:
6.09x
Enterprise value / EBITDA:
2.92x
Gross Profit (TTM):
$1.5B
Return On Assets:
40.34%
Net Income Margin (TTM):
26.08%
Return On Equity:
50.26%
Return On Invested Capital:
50.26%
Operating Margin:
44.87%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Income Statement | ||||||
| Revenue | $3.1B | -- | $3.8B | -- | $1.4B | |
| Gross Profit | $1.2B | -- | $1.5B | -- | $716.1M | |
| Operating Income | $971.8M | -- | $1.2B | -- | $636.1M | |
| EBITDA | $1.1B | -- | $1.4B | -- | $659.8M | |
| Diluted EPS | $15.52 | -- | $20.23 | -- | $10.38 | |
| Period Ending | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $522.9M | $522.7M | $1.2B | -- | $2B | |
| Total Assets | $1.2B | $1.3B | $2B | -- | $3.1B | |
| Current Liabilities | $100.8M | $121.4M | $313.1M | -- | $513.7M | |
| Total Liabilities | $214.8M | $251.8M | $457.6M | -- | $694.1M | |
| Total Equity | $1B | $1B | $1.5B | -- | $2.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-28 | 2024-02-28 | 2025-02-28 | 2024-02-28 | 2025-02-28 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $811.9M | -- | $1B | -- | $571.6M | |
| Cash From Investing | -$453.3M | -- | -$679.3M | -- | -$137.7M | |
| Cash From Financing | -$152.5M | -- | -$216.1M | -- | -$76.9M | |
| Free Cash Flow | $702.5M | -- | $859M | -- | $521.8M | |
CALM
Sector
Market Cap
$5.2B
$249.4M
Price % of 52-Week High
91.75%
75%
Dividend Yield
6.34%
0%
Shareholder Yield
4.82%
2.89%
1-Year Price Total Return
62.8%
-10.33%
Beta (5-Year)
0.174
0.377
Dividend yield:
6.34%
Annualized payout:
$1.87
Payout ratio:
21.16%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$102.66
200-day SMA
Buy
Level
$96.09
Bollinger Bands (100)
Buy
Level
89.54 - 99.74
Chaikin Money Flow
Buy
Level
31.4M
20-day SMA
Buy
Level
$101.79
Relative Strength Index (RSI14)
Buy
Level
67.74
ADX Line
Buy
Level
11.18
Williams %R
Sell
Level
-1.3078
50-day SMA
Buy
Level
$98.17
MACD (12, 26)
Buy
Level
1.70
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
107.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.9719)
Buy
CA Score
(Annual)
Level (2.2498)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-3.7386)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
Stock Forecast FAQ
In the current month, CALM has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CALM average analyst price target in the past 3 months is $105.33.
-
Where Will Cal-Maine Foods Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cal-Maine Foods share price will drop to $105.33 per share over the next 12 months.
-
What Do Analysts Say About Cal-Maine Foods?
Analysts are divided on their view about Cal-Maine Foods share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cal-Maine Foods is a Sell and believe this share price will rise from its current level to $100.00.
-
What Is Cal-Maine Foods's Price Target?
The price target for Cal-Maine Foods over the next 1-year time period is forecast to be $105.33 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is CALM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cal-Maine Foods is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CALM?
You can purchase shares of Cal-Maine Foods via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cal-Maine Foods shares.
-
What Is The Cal-Maine Foods Share Price Today?
Cal-Maine Foods was last trading at $106.77 per share. This represents the most recent stock quote for Cal-Maine Foods. Yesterday, Cal-Maine Foods closed at $106.81 per share.
-
How To Buy Cal-Maine Foods Stock Online?
In order to purchase Cal-Maine Foods stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
